Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

High-Versus Low-Dose Warfarin-Related Teratogenicity: A Case Report and Systematic Review.

Dhillon SK, Edwards J, Wilkie J, Bungard TJ.

J Obstet Gynaecol Can. 2018 Oct;40(10):1348-1357. doi: 10.1016/j.jogc.2017.11.020. Review.

PMID:
30390948
2.

Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals.

Bungard TJ, Ritchie B, Bolt J, Semchuk WM.

BMJ Open. 2018 Oct 31;8(10):e022065. doi: 10.1136/bmjopen-2018-022065.

3.

Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency department.

Bungard TJ, Ritchie B, Bolt J, Semchuk WM.

BMJ Open. 2018 Oct 31;8(10):e022064. doi: 10.1136/bmjopen-2018-022064.

4.
5.

Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation.

Sandhu RK, Guirguis LM, Bungard TJ, Youngson E, Dolovich L, Brehaut JC, Healey JS, McAlister FA.

Can Pharm J (Ott). 2017 Nov 29;151(1):51-61. doi: 10.1177/1715163517743269. eCollection 2018 Jan-Feb.

6.

Apixaban Concentration with and without Coadministration of Carbamazepine: A Case with No Apparent Interaction.

Evanger N, Szkotak A, Stang L, Bungard TJ.

Can J Hosp Pharm. 2017 Nov-Dec;70(6):463-467. Epub 2017 Dec 21. No abstract available.

7.

A Case of Migraine With Aura Resolving on Warfarin But Not on Apixaban.

Nilsson BG, Bungard TJ.

Headache. 2017 Nov;57(10):1614-1617. doi: 10.1111/head.13190. Epub 2017 Sep 27.

PMID:
28960288
8.

A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure.

Bungard TJ, Mutch J, Ritchie B.

J Thromb Thrombolysis. 2017 Nov;44(4):507-515. doi: 10.1007/s11239-017-1553-6.

PMID:
28914415
9.

Venous Thromboembolism Prophylaxis on General Internal Medicine Units: Are Patients Well Served by Current Practice?

Mejilla A, Guirguis M, Koshman S, Bungard TJ.

Can J Hosp Pharm. 2017 May-Jun;70(3):200-206. Epub 2017 Jun 30.

10.

The management of venous thromboembolism: A practical tool for the front-line clinician.

Bungard TJ, Semchuk W.

Can Pharm J (Ott). 2017 Feb 9;150(2):81-89. doi: 10.1177/1715163517691062. eCollection 2017 Mar-Apr. No abstract available.

11.

Critical international normalized ratio results after hours: To call or not to call?

Korn D, Sean McMurtry M, George-Phillips K, Bungard TJ.

Can Fam Physician. 2017 Mar;63(3):e170-e176.

12.

Checklists for the use of novel oral anticoagulants by the front-line clinician.

Bungard TJ, Bolt J, Thomson P, Semchuk W, Lowerison J.

Can Pharm J (Ott). 2015 Sep;148(5):241-5. doi: 10.1177/1715163515596758. No abstract available.

13.

More than Just Chasing INRs: Patient-Centred Care in an Anticoagulation Clinic.

Boswell R, Bungard TJ.

Can J Hosp Pharm. 2015 May-Jun;68(3):254-7. No abstract available.

14.

The Disconnect Between Novel Oral Anticoagulant Eligibility and Provincial Drug Coverage: An Albertan Anticoagulation Clinic Audit.

Dhillon SK, McMurtry MS, Bungard TJ.

Can J Cardiol. 2015 Aug;31(8):1047-50. doi: 10.1016/j.cjca.2015.02.027. Epub 2015 Feb 25.

PMID:
26095931
15.

Warfarin Re-initiation Gone Awry: A Case of Inadvertent Overdose Mandating Critical INR Management.

Bungard TJ, Gee A.

Can J Hosp Pharm. 2015 Mar-Apr;68(2):161-7. No abstract available.

16.

A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?

Berresheim M, Wilkie J, Nerenberg KA, Ibrahim Q, Bungard TJ.

Thromb Res. 2014 Dec;134(6):1234-40. doi: 10.1016/j.thromres.2014.09.033. Epub 2014 Oct 2.

PMID:
25450535
17.

Cardiovascular risk factor modification among high-risk patients: Do pharmacists play a role?

Chow J, Bungard TJ.

Can Pharm J (Ott). 2013 Sep;146(5):257-61. doi: 10.1177/1715163513499125. No abstract available.

18.

Patient satisfaction with services provided by multidisciplinary anticoagulation clinics.

Bungard TJ, Barry AR, Jones C, Brocklebank C.

Pharmacotherapy. 2013 Nov;33(11):1246-51. doi: 10.1002/phar.1318. Epub 2013 Jun 24.

PMID:
23798320
19.

Evaluation of a multi staged professional development course for practising pharmacists in anticoagulation management.

Bungard TJ, Schindel TJ, Garg S, Brocklebank C.

Int J Pharm Pract. 2012 Apr;20(2):107-17. doi: 10.1111/j.2042-7174.2011.00171.x. Epub 2011 Oct 13.

PMID:
22416935
20.

Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician.

Bungard TJ, Ritchie B, Garg S, Tsuyuki RT.

Pharmacotherapy. 2012 Feb;32(2):112-9. doi: 10.1002/PHAR.1011.

PMID:
22392419
21.

A description of a multistaged professional development course for practising pharmacists in anticoagulation management.

Bungard TJ, Schindel TJ, Brocklebank C.

Can Pharm J (Ott). 2012 Jan;145(1):14-16.e1. doi: 10.3821/1913-701X-145.1.14. No abstract available.

22.

Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.

Schultz KT, Bungard TJ.

Pharmacotherapy. 2011 Aug;31(8):793-805. doi: 10.1592/phco.31.8.793.

PMID:
21923606
23.

New anticoagulants for atrial fibrillation: the beginning of a a new era in stroke prevention.

Gladstone DJ, Earl KM, Bungard TJ, Cox JL, Bell A, Dorian P, Dean N, Huynh T, Chopra A, Eikelboom J, Shuaib A.

Can J Neurol Sci. 2011 Sep;38(5):777-82. Review. No abstract available.

PMID:
21856588
24.

Valvular heart disease: a primer for the clinical pharmacist.

Bungard TJ, Sonnenberg B.

Pharmacotherapy. 2011 Jan;31(1):76-91. doi: 10.1592/phco.31.1.76. Review.

PMID:
21182361
25.

Direct and indirect costs of management of long-term warfarin therapy in Canada.

Schulman S, Anderson DR, Bungard TJ, Jaeger T, Kahn SR, Wells P, Wilson SJ.

J Thromb Haemost. 2010 Oct;8(10):2192-200. doi: 10.1111/j.1538-7836.2010.03989.x.

26.

Cardiac EASE (Ensuring Access and Speedy Evaluation) - the impact of a single-point-of-entry multidisciplinary outpatient cardiology consultation program on wait times in Canada.

Bungard TJ, Smigorowsky MJ, Lalonde LD, Hogan T, Doliszny KM, Gebreyesus G, Garg S, Archer SL.

Can J Cardiol. 2009 Dec;25(12):697-702. English, French.

27.

Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care.

Bungard TJ, Gardner L, Archer SL, Hamilton P, Ritchie B, Tymchak W, Tsuyuki RT.

Open Med. 2009 Feb 2;3(1):e16-21.

28.

Cardiac EASE (Ensuring Access and Speedy Evaluation)--design of a single point of entry and a multidisciplinary team to reduce waiting times in the Canadian health care system.

Bungard TJ, Smigorowsky MJ, Lalonde LD, Hogan T, Maier E, Archer SL.

Healthc Manage Forum. 2008 Autumn;21(3):35-40.

PMID:
19086484
29.

Prescribing by pharmacists in Alberta.

Yuksel N, Eberhart G, Bungard TJ.

Am J Health Syst Pharm. 2008 Nov 15;65(22):2126-32. doi: 10.2146/ajhp080247.

PMID:
18997141
30.

Patient preferences for ongoing warfarin management after receiving care by an anticoagulation management service.

Bungard TJ, Koshman SL, Tsuyuki RT.

Am J Health Syst Pharm. 2008 Aug 15;65(16):1498-500. doi: 10.2146/ajhp070274. No abstract available.

PMID:
18693199
31.

Management of hypothyroidism during pregnancy.

Bungard TJ, Hurlburt M.

CMAJ. 2007 Apr 10;176(8):1077-8. No abstract available.

32.

Use of low-molecular-weight heparin to bridge therapy in obese patients and in patients with renal dysfunction.

George-Phillips KL, Bungard TJ.

Pharmacotherapy. 2006 Oct;26(10):1479-90. Review.

PMID:
16999658
33.

A multicenter disease management program for hospitalized patients with heart failure.

Tsuyuki RT, Fradette M, Johnson JA, Bungard TJ, Eurich DT, Ashton T, Gordon W, Ikuta R, Kornder J, Mackay E, Manyari D, O'Reilly K, Semchuk W.

J Card Fail. 2004 Dec;10(6):473-80.

PMID:
15599837
34.

Development of educational materials for congestive-heart-failure patients.

Fradette M, Bungard TJ, Simpson SH, Tsuyuki RT.

Am J Health Syst Pharm. 2004 Feb 15;61(4):386-9. No abstract available.

PMID:
15011767
35.

Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation.

Lau E, Bungard TJ, Tsuyuki RT.

J Am Geriatr Soc. 2004 Mar;52(3):428-33.

PMID:
14962160
36.

The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.

Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, Mitchell LB, Shuaib A, Teo KK, Tsuyuki RT.

Can J Cardiol. 2003 Mar 15;19(3):280-4.

PMID:
12677283
37.

Underutilisation of ACE inhibitors in patients with congestive heart failure.

Bungard TJ, McAlister FA, Johnson JA, Tsuyuki RT.

Drugs. 2001;61(14):2021-33. Review.

PMID:
11735631
38.

Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.

Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, Mitchell LB, Shuaib A, Teo KK, Tsuyuki RT.

CMAJ. 2001 Aug 7;165(3):301-2. No abstract available.

39.

Cholesterol risk management: a systematic examination of the gap from evidence to practice.

Olson KL, Bungard TJ, Tsuyuki RT.

Pharmacotherapy. 2001 Jul;21(7):807-17. Review.

PMID:
11444577
40.

Poor adherence with hypolipidemic drugs: a lost opportunity.

Tsuyuki RT, Bungard TJ.

Pharmacotherapy. 2001 May;21(5):576-82.

PMID:
11349746
41.

Stroke prophylaxis in nonvalvular atrial fibrillation.

Bungard TJ, Shuaib A, Tsuyuki RT.

Curr Opin Neurol. 2001 Feb;14(1):59-65. Review.

PMID:
11176219
42.

Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital.

Bungard TJ, Ackman ML, Ho G, Tsuyuki RT.

Pharmacotherapy. 2000 Sep;20(9):1060-5.

PMID:
10999498
43.

Why do patients with atrial fibrillation not receive warfarin?

Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT.

Arch Intern Med. 2000 Jan 10;160(1):41-6. Review.

PMID:
10632303
44.

An overview of commonly used antiplatelet agents.

Bungard TJ.

Can J Cardiovasc Nurs. 1998;9(3):38-46. Review.

PMID:
10335141
45.

Prokinetic agents for the treatment of postoperative ileus in adults: a review of the literature.

Bungard TJ, Kale-Pradhan PB.

Pharmacotherapy. 1999 Apr;19(4):416-23. Review.

PMID:
10212012

Supplemental Content

Loading ...
Support Center